Fluvoxamine is a prescription medication approved by the FDA to treat obsessive-compulsive disorder (OCD). It belongs to the selective serotonin reuptake inhibitor (SSRI) class of antidepressants and is one of the few SSRIs specifically approved for OCD in both adults and children ages 8 and older. It’s sold under the brand name Luvox and is also available as a generic.
How Fluvoxamine Works
Like other SSRIs, fluvoxamine blocks the reabsorption of serotonin in the brain, leaving more of it available in the spaces between nerve cells. Serotonin plays a key role in regulating mood, anxiety, and repetitive behaviors, which is why boosting its availability helps reduce OCD symptoms. Fluvoxamine is actually a more potent blocker of serotonin reabsorption than the older tricyclic antidepressants that were once the standard treatment.
What sets fluvoxamine apart from other SSRIs is its activity at sigma-1 receptors, a type of receptor in the brain that may be involved in cognitive function. The clinical significance of this isn’t fully understood, but animal research suggests it could play a role in improving thinking and memory problems associated with depression.
Its Primary Use: Obsessive-Compulsive Disorder
OCD is the only FDA-approved indication for fluvoxamine. The medication is available in two forms: immediate-release tablets and extended-release capsules. For adults, immediate-release treatment typically starts at 50 mg taken once daily at bedtime, with the dose gradually increased every four to seven days until symptoms improve. The maximum daily dose is 300 mg. Once the dose exceeds 100 mg per day, it’s usually split into two doses, with the larger portion taken at bedtime.
For children and adolescents ages 8 to 17, the starting dose is lower at 25 mg daily. Children under 12 can go up to 200 mg per day, while adolescents can reach the full adult dose of 300 mg. Doses above 50 mg per day are typically divided into two daily doses. The extended-release capsule version starts at 100 mg once daily at bedtime for adults.
It generally takes about a week for fluvoxamine to build up to stable levels in your bloodstream. The medication has a half-life of roughly 15.6 hours, meaning your body clears about half of a dose in that time. Full therapeutic effects for OCD often take several weeks to become noticeable, so patience during the early adjustment period is important.
Off-Label Uses
While OCD is the only condition on the label, fluvoxamine is widely prescribed for several other mental health conditions. According to NAMI (the National Alliance on Mental Illness), common off-label uses include:
- Major depressive disorder
- Generalized anxiety disorder
- Social anxiety disorder (social phobia)
- Post-traumatic stress disorder (PTSD)
- Panic disorder
- Body dysmorphic disorder
- Eating disorders, including bulimia nervosa and binge-eating disorder
“Off-label” means the FDA hasn’t formally reviewed and approved the drug for that specific condition, but physicians can still prescribe it based on clinical evidence and their professional judgment. Off-label prescribing is common across all of medicine and doesn’t mean the use is experimental. In many countries outside the U.S., fluvoxamine is approved for depression as a primary indication.
Fluvoxamine and COVID-19
During the pandemic, fluvoxamine attracted attention as a potential treatment for COVID-19, partly because of its anti-inflammatory properties linked to sigma-1 receptor activity. Early, smaller studies generated some optimism. However, the large ACTIV-6 randomized clinical trial, which enrolled 1,175 outpatients with mild to moderate COVID-19, found no benefit. Participants who took fluvoxamine (100 mg twice daily) recovered in a median of 10 days, exactly the same as those who took a placebo. Based on this evidence, fluvoxamine is not recommended for COVID-19 treatment.
Common Side Effects
Fluvoxamine shares the general side effect profile of other SSRIs. The most frequently reported issues include nausea, drowsiness, insomnia, dizziness, dry mouth, and sexual side effects such as decreased libido or difficulty reaching orgasm. Nausea tends to be the most common early complaint but often improves after the first week or two as your body adjusts. Taking the medication at bedtime, as recommended, helps minimize daytime drowsiness.
Like all antidepressants, fluvoxamine carries an FDA boxed warning about an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults under 25 during the first few months of treatment or after dose changes. This doesn’t mean the medication causes suicidal behavior in most people, but it does mean close monitoring during the early weeks is important, especially for younger patients.
Drug Interactions to Know About
Fluvoxamine stands out among SSRIs for how strongly it affects the way your body processes other medications. The FDA classifies it as a strong inhibitor of two key liver enzymes (CYP1A2 and CYP2C19) and a moderate inhibitor of a third (CYP3A). In practical terms, this means fluvoxamine can dramatically increase blood levels of other drugs that rely on these enzymes to be broken down.
A “strong inhibitor” can increase the effective concentration of another drug by five times or more. This is clinically significant for people taking caffeine (which is processed by CYP1A2), certain blood thinners, some heart medications, theophylline for asthma, and the sleep aid melatonin, among many others. If you’re prescribed fluvoxamine, your provider needs a complete list of everything else you take, including over-the-counter supplements. You may also notice that caffeine hits you much harder than before, since fluvoxamine substantially slows its breakdown.
Fluvoxamine should never be combined with monoamine oxidase inhibitors (MAOIs) or thioridazine due to the risk of dangerous, potentially fatal interactions.